Ebrahimi-Fakhari_2022_Mol.Genet.Metab_137_436

Reference

Title : Childhood-onset hereditary spastic paraplegia and its treatable mimics - Ebrahimi-Fakhari_2022_Mol.Genet.Metab_137_436
Author(s) : Ebrahimi-Fakhari D , Saffari A , Pearl PL
Ref : Mol Genet Metab , 137 :436 , 2022
Abstract :

Early-onset forms of hereditary spastic paraplegia and inborn errors of metabolism that present with spastic diplegia are among the most common "mimics" of cerebral palsy. Early detection of these heterogenous genetic disorders can inform genetic counseling, anticipatory guidance, and improve outcomes, particularly where specific treatments exist. The diagnosis relies on clinical pattern recognition, biochemical testing, neuroimaging, and increasingly next-generation sequencing-based molecular testing. In this short review, we summarize the clinical and molecular understanding of: 1) childhood-onset and complex forms of hereditary spastic paraplegia (SPG5, SPG7, SPG11, SPG15, SPG35, SPG47, SPG48, SPG50, SPG51, SPG52) and, 2) the most common inborn errors of metabolism that present with phenotypes that resemble hereditary spastic paraplegia.

PubMedSearch : Ebrahimi-Fakhari_2022_Mol.Genet.Metab_137_436
PubMedID: 34183250

Related information

Citations formats

Ebrahimi-Fakhari D, Saffari A, Pearl PL (2022)
Childhood-onset hereditary spastic paraplegia and its treatable mimics
Mol Genet Metab 137 :436

Ebrahimi-Fakhari D, Saffari A, Pearl PL (2022)
Mol Genet Metab 137 :436